SCHEMBL31437051

SCHEMBL31437051

CC(C)(C)OC(=O)NC1CCN(S(=O)(=O)c2cccc(OC3CNC3)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.46
PKM P14618 4/20 0.45
KMT2A Q03164 5/20 0.45
ALDH1A1 P00352 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
EPHX2 P34913 1/20 0.43
BRD4 O60885 2/20 0.42
MEN1 O00255 2/20 0.42
HTT P42858 1/20 0.42
TSHR P16473 1/20 0.42
HTR2C P28335 1/20 0.42
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24571567 1.00 NAMPT (0.46) NAMPTPKMKMT2AALDH1A1KDM4E
SCHEMBL24571700 0.92 UTS2R (0.47) NAMPTPKMKMT2AALDH1A1SMN1; SMN2
SCHEMBL31437042 0.92 UTS2R (0.47) NAMPTPKMKMT2AALDH1A1SMN1; SMN2
SCHEMBL24571898 0.91 KMT2A (0.42) NAMPTPKMKMT2AALDH1A1SMN1; SMN2
SCHEMBL24571532 0.88 NAMPT (0.52) NAMPTPKMKMT2AALDH1A1SMN1; SMN2
SCHEMBL24571634 0.88 BRD4 (0.43) NAMPTPKMKMT2AALDH1A1SMN1; SMN2
SCHEMBL29640988 0.86 ALDH1A1 (0.50) PKMKMT2AALDH1A1KDM4EEPHX2
SCHEMBL24711651 0.86 PKM (0.54) PKMKMT2AALDH1A1KDM4ESMN1; SMN2
SCHEMBL24571940 0.85 PKM (0.48) NAMPTPKMKMT2AALDH1A1KDM4E
SCHEMBL24571568 0.83 CCR5 (0.48) NAMPTPKMKMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120152967-A Bifunctional compounds containing 2, 5-substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-06-13 CN disclosed
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed